Skip to main content

Animations

MJFF Publications

5091 - 5100 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2017
  • 2017
  • 2018
  • 2019
  • 2018
  • 2024
  • 2017
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands
    Journal Name: ACS Medicinal Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0153-4
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Dual-Task Performance in GBA Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2017/8582740
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain
    Journal Name: Molecular Therapy - Methods & Clinical Development
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008
    Citation Count: 18
  • Summary Details
    OPEN
    Title: The good and bad of therapeutic strategies that directly target α‐synuclein
    Journal Name: IUBMB Life
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/iub.2194
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2024.106691
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cells
    Journal Name: Open Biology
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1098/rsob.210264
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N -arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity
    Journal Name: RSC Chemical Biology
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d1cb00103e
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.